North America diabetes care drugs market is anticipated to grow significantly over the forecast period. The US and Canada are the two major economies contributing to the growth of the market. The key factor that drives the growth of the North American diabetes care drug industry includes the increased prevalence of diabetes across the region.
According to IDF (International Diabetes Federation), in 2019, the prevalence of diabetes was around 13.3% of the total adult population in the region which is expected to increase up to 14.2% by 2030 and 15% by 2045. Thus, the increased prevalence of diabetes will create demand for diabetes drugs and thus provides growth opportunities for the market in the forecast period.
Further, the presence of the key players such as Bayer AG, Bausch Health Companies Inc., Bristol Myers Squibb Co., Eli Lilly and Co., Merck & Co. Inc., Novartis International AG, Novo Nordisk A/S, Pfizer Inc., among others also contributes to the growth of the market. These players adopt several growth strategies such as product launches, mergers and acquisitions, product innovations, and others. For instance, in February 2020, Sun Pharmaceutical Industries through its wholly-owned subsidiary launched Riomet ER, used to treat type 2 diabetes mellitus, in the US market. Riomet ER is the first and only US FDA-approved liquid formulation of extended-release metformin.
To Request a Sample of our Report on North America Diabetes Care Drugs Market: https://www.omrglobal.com/request-sample/north-american-diabetes-care-drugs-market
Market Coverage
- Market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered- By Drug Class
- Region Covered- North America
- Competitive Landscape- Bausch Health Companies Inc., Bristol Myers Squibb Co., Eli Lilly and Co., Merck & Co. Inc., Novartis International AG, Novo Nordisk A/S, Pfizer Inc., and Takeda Pharmaceuticals Industries Ltd.
North America Diabetes Care Drugs Market – Segmentation
By Drug Class
- Insulins
- Non-Insulin Injectable Drugs
- Oral Anti-Diabetic Drugs
- Combination Drugs
A full Report of North America Diabetes Care Drugs Market is Available at: https://www.omrglobal.com/industry-reports/north-american-diabetes-care-drugs-market
North America Diabetes Care Drugs Market – Countries Covered
North America
- US
- Canada
Company Profiles
- AstraZeneca Plc
- Bayer AG
- Bausch Health Companies Inc.
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- Johnson & Johnson Services Inc.
- Merck & Co. Inc.
- Mylan NV
- Nectar Therapeutics
- Novartis International AG
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceuticals Industries Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
